Evidence map›Paper›PMID 31296844›Full record

ArticleCell death & disease2019

cPLA2 activation contributes to lysosomal defects leading to impairment of autophagy after spinal cord injury.

Yun Li, Jace W Jones, Harry M C Choi, Chinmoy Sarkar, Maureen A Kane, Eugene Y Koh, Marta M Lipinski, Junfang Wu

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Arachidonic acid metabolism in spinal cord injury.Journal of advanced research · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. APOE-Targeted Therapeutics for Alzheimer's Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yun LiDepartment of Anesthesiology & Center for Shock, Trauma and Anesthesiology Research (STAR), School of Medicine, University of Maryland, Baltimore, MD, USA.
Jace W JonesDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD, USA.
Harry M C ChoiDepartment of Anesthesiology & Center for Shock, Trauma and Anesthesiology Research (STAR), School of Medicine, University of Maryland, Baltimore, MD, USA.
Chinmoy SarkarDepartment of Anesthesiology & Center for Shock, Trauma and Anesthesiology Research (STAR), School of Medicine, University of Maryland, Baltimore, MD, USA.
Maureen A KaneDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD, USA.
Eugene Y KohDepartment of Orthopedics, School of Medicine, University of Maryland, Baltimore, MD, USA.
Marta M LipinskiDepartment of Anesthesiology & Center for Shock, Trauma and Anesthesiology Research (STAR), School of Medicine, University of Maryland, Baltimore, MD, USA. mlipinski@som.umaryland.edu.
Junfang WuDepartment of Anesthesiology & Center for Shock, Trauma and Anesthesiology Research (STAR), School of Medicine, University of Maryland, Baltimore, MD, USA. junfang.wu@som.umaryland.edu.
University of Maryland, Baltimore · US

Funding

Spinal Mechanisms Underlying SCI-Induced Pain: Implications for Targeted TherapyR01NR013601 · NINR · UNIVERSITY OF MARYLAND BALTIMORE · PI DORSEY, SUSAN G, FADEN, ALAN IRA · 2012 to 2021
$6.0M
The new roles of the autophagy-lysosomal pathway in spinal cord injury-mediated dementiaR01NS094527 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI MARTA M LIPINSKI, Junfang Wu · 2016 to 2026
$3.5M
Targeting brain inflammation and neurocognitive dysfunction in sepsisR01NS110567 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI CHAO, WEI, WU, JUNFANG · 2019 to 2024
$2.5M
Mechanism of Inflammatory Related Brain Dysfunction after Spinal Cord InjuryR01NS110635 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI FADEN, ALAN IRA, WU, JUNFANG · 2019 to 2023
$2.2M
Function and Mechanisms of Autophagy-Lysosomal Pathway in Traumatic Brain InjuryR01NS091218 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI LIPINSKI, MARTA M · 2015 to 2019
$1.8M
NINDS NIH HHS R01 NS091218NINDS NIH HHS R01 NS094527NINDS NIH HHS R01 NS110567NINDS NIH HHS R01 NS110635NINR NIH HHS R01 NR013601
6 · The paper itself

Abstract

The autophagy-lysosomal pathway plays an essential role in cellular homeostasis as well as a protective function against a variety of diseases including neurodegeneration. Conversely, inhibition of autophagy, for example due to lysosomal dysfunction, can lead to pathological accumulation of dysfunctional autophagosomes and consequent neuronal cell death. We previously reported that autophagy is inhibited and contributes to neuronal cell death following spinal cord injury (SCI). In this study, we examined lysosomal function and explored the mechanism of lysosomal defects following SCI. Our data demonstrated that expression levels and processing of the lysosomal enzyme cathepsin D (CTSD) are decreased by 2 h after SCI. Enzymatic activity levels of CTSD and another lysosomal enzyme, N-acetyl-alpha-glucosaminidase, are both decreased 24 h post injury, indicating general lysosomal dysfunction. Subcellular fractionation and immunohistochemistry analysis demonstrated that this dysfunction is due to lysosomal membrane permeabilization and leakage of lysosomal contents into the cytosol. To directly assess extent and mechanisms of damage to lysosomal membranes, we performed mass spectrometry-based lipidomic analysis of lysosomes purified from SCI and control spinal cord. At 2 h post injury our data demonstrated increase in several classes of lysosophospholipids, the products of phospholipases (PLAs), as well as accumulation of PLA activators, ceramides. Phospholipase cPLA2, the main PLA species expressed in the CNS, has been previously implicated in mediation of secondary injury after SCI, but the mechanisms of its involvement remain unclear. Our data demonstrate that cPLA2 is activated within 2 h after SCI preferentially in the lysosomal fraction, where it colocalizes with lysosomal-associated membrane protein 2 in neurons. Inhibition of cPLA2 in vivo decreased lysosomal damage, restored autophagy flux, and reduced neuronal cell damage. Taken together our data implicate lysosomal defects in pathophysiology of SCI and for the first time indicate that cPLA2 activation leads to lysosomal damage causing neuronal autophagosome accumulation associated with neuronal cell death.

Indexed as

Autophagyalpha-N-AcetylgalactosaminidaseAnimalsAutophagosomesCathepsin DCell DeathLysosomal-Associated Membrane Protein 2LysosomesMaleMiceMice, Inbred C57BLNeuronsPhospholipases A2, CytosolicPhospholipidsSequestosome-1 ProteinSpinal Cordalpha-N-AcetylgalactosaminidaseCathepsin DLysosomal-Associated Membrane Protein 2Phospholipases A2, CytosolicPhospholipidsSequestosome-1 ProteinSqstm1 protein, mouse

Identifiers

PMID31296844
PMCPMC6624263
OpenAlexW2957113653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.